| Year |
Citation |
Score |
| 2022 |
Luu L, Bah GS, Okah-Nnane NH, Hartley CS, Glover AF, Walsh TR, Lian LY, Zhan B, Bottazzi ME, Abraham D, Petrovsky N, Bayang N, Tangwa B, Ayiseh RB, Mbah GE, ... ... Lustigman S, et al. Co-Administration of Adjuvanted Recombinant -103 and -RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Infection Model of Human Onchocerciasis. Vaccines. 10. PMID 35746469 DOI: 10.3390/vaccines10060861 |
0.363 |
|
| 2022 |
Zhan B, Bottazzi ME, Hotez PJ, Lustigman S. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With . Frontiers in Cellular and Infection Microbiology. 12: 869039. PMID 35444961 DOI: 10.3389/fcimb.2022.869039 |
0.317 |
|
| 2021 |
Abraham D, Graham-Brown J, Carter D, Gray SA, Hess JA, Makepeace BL, Lustigman S. Development of a recombinant vaccine against human onchocerciasis. Expert Review of Vaccines. PMID 34488533 DOI: 10.1080/14760584.2021.1977125 |
0.35 |
|
| 2020 |
Srey MT, Taccogna A, Oksov Y, Lustigman S, Tai PY, Acord J, Selkirk ME, Lamb TJ, Guiliano DB. Vaccination with novel low-molecular weight proteins secreted from Trichinella spiralis inhibits establishment of infection. Plos Neglected Tropical Diseases. 14: e0008842. PMID 33206649 DOI: 10.1371/journal.pntd.0008842 |
0.332 |
|
| 2020 |
Hübner MP, Martin C, Specht S, Koschel M, Dubben B, Frohberger SJ, Ehrens A, Fendler M, Struever D, Mitre E, Vallarino-Lhermitte N, Gokool S, Lustigman S, Schneider M, Townson S, et al. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro. Plos Neglected Tropical Diseases. 14: e0008427. PMID 32628671 DOI: 10.1371/Journal.Pntd.0008427 |
0.317 |
|
| 2020 |
Grote A, Li Y, Liu C, Voronin D, Geber A, Lustigman S, Unnasch TR, Welch L, Ghedin E. Prediction pipeline for discovery of regulatory motifs associated with Brugia malayi molting. Plos Neglected Tropical Diseases. 14: e0008275. PMID 32574217 DOI: 10.1371/Journal.Pntd.0008275 |
0.347 |
|
| 2020 |
George PJ, Tai W, Du L, Lustigman S. The Potency of an Anti-MERS Coronavirus Subunit Vaccine Depends on a Unique Combinatorial Adjuvant Formulation. Vaccines. 8. PMID 32471056 DOI: 10.3390/Vaccines8020251 |
0.416 |
|
| 2019 |
Voronin D, Schnall E, Grote A, Jawahar S, Ali W, Unnasch TR, Ghedin E, Lustigman S. Pyruvate produced by Brugia spp. via glycolysis is essential for maintaining the mutualistic association between the parasite and its endosymbiont, Wolbachia. Plos Pathogens. 15: e1008085. PMID 31568486 DOI: 10.1371/Journal.Ppat.1008085 |
0.352 |
|
| 2019 |
Kashyap SS, Verma S, Voronin D, Lustigman S, Kulke D, Robertson AP, Martin RJ. Emodepside has sex-dependent immobilizing effects on adult Brugia malayi due to a differentially spliced binding pocket in the RCK1 region of the SLO-1 K channel. Plos Pathogens. 15: e1008041. PMID 31553770 DOI: 10.1371/Journal.Ppat.1008041 |
0.311 |
|
| 2019 |
P JG, Hess JA, Jain S, Patton JB, Zhan T, Tricoche N, Zhan B, Bottazzi ME, Hotez PJ, Abraham D, Lustigman S. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans. Plos Neglected Tropical Diseases. 13: e0007730. PMID 31525197 DOI: 10.1371/Journal.Pntd.0007730 |
0.437 |
|
| 2019 |
Bennuru S, Oduro-Boateng G, Osigwe C, Del-Valle P, Golden A, Ogawa GM, Cama V, Lustigman S, Nutman TB. Integrating multiple biomarkers to increase sensitivity for the detection of Onchocerca volvulus infection. The Journal of Infectious Diseases. PMID 31201416 DOI: 10.1093/Infdis/Jiz307 |
0.361 |
|
| 2019 |
Voronin D, Tricoche N, Jawahar S, Shlossman M, Bulman CA, Fischer C, Suderman MT, Sakanari JA, Lustigman S. Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms. Plos Neglected Tropical Diseases. 13: e0007108. PMID 30653499 DOI: 10.1371/Journal.Pntd.0007108 |
0.37 |
|
| 2019 |
Fischer C, Ibiricu Urriza I, Bulman CA, Lim KC, Gut J, Lachau-Durand S, Engelen M, Quirynen L, Tekle F, Baeten B, Beerntsen B, Lustigman S, Sakanari J. Efficacy of subcutaneous doses and a new oral amorphous solid dispersion formulation of flubendazole on male jirds (Meriones unguiculatus) infected with the filarial nematode Brugia pahangi. Plos Neglected Tropical Diseases. 13: e0006787. PMID 30650084 DOI: 10.1371/Journal.Pntd.0006787 |
0.31 |
|
| 2018 |
Patton JB, Bennuru S, Eberhard ML, Hess JA, Torigian A, Lustigman S, Nutman TB, Abraham D. Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum. Plos Neglected Tropical Diseases. 12: e0006977. PMID 30540742 DOI: 10.1371/Journal.Pntd.0006977 |
0.351 |
|
| 2018 |
Zhan B, Arumugam S, Kennedy MW, Tricoche N, Lian LY, Asojo OA, Bennuru S, Bottazzi ME, Hotez PJ, Lustigman S, Klei TR. Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils. Plos Neglected Tropical Diseases. 12: e0006772. PMID 30296268 DOI: 10.1371/Journal.Pntd.0006772 |
0.42 |
|
| 2018 |
Grote A, Caffrey CR, Rebello KM, Smith D, Dalton JP, Lustigman S. Cysteine proteases during larval migration and development of helminths in their final host. Plos Neglected Tropical Diseases. 12: e0005919. PMID 30138448 DOI: 10.1371/Journal.Pntd.0005919 |
0.391 |
|
| 2018 |
Liu C, Mhashilkar AS, Chabanon J, Xu S, Lustigman S, Adams JH, Unnasch TR. Development of a toolkit for piggyBac-mediated integrative transfection of the human filarial parasite Brugia malayi. Plos Neglected Tropical Diseases. 12: e0006509. PMID 29782496 DOI: 10.1371/Journal.Pntd.0006509 |
0.359 |
|
| 2018 |
Jain S, George PJ, Deng W, Koussa J, Parkhouse K, Hensley SE, Jiang J, Lu J, Liu Z, Wei J, Zhan B, Bottazzi ME, Shen H, Lustigman S. The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. Vaccine. PMID 29764680 DOI: 10.1016/J.Vaccine.2018.05.029 |
0.415 |
|
| 2017 |
Lustigman S, Makepeace BL, Klei TR, Babayan SA, Hotez P, Abraham D, Bottazzi ME. Onchocerca volvulus: The Road from Basic Biology to a Vaccine. Trends in Parasitology. PMID 28958602 DOI: 10.1016/J.Pt.2017.08.011 |
0.377 |
|
| 2017 |
Grote A, Voronin D, Ding T, Twaddle A, Unnasch TR, Lustigman S, Ghedin E. Defining Brugia malayi and Wolbachia symbiosis by stage-specific dual RNA-seq. Plos Neglected Tropical Diseases. 11: e0005357. PMID 28358880 DOI: 10.1371/Journal.Pntd.0005357 |
0.355 |
|
| 2017 |
Bennuru S, Lustigman S, Abraham D, Nutman TB. Metabolite profiling of infection-associated metabolic markers of onchocerciasis. Molecular and Biochemical Parasitology. PMID 28188804 DOI: 10.1016/J.Molbiopara.2017.01.008 |
0.321 |
|
| 2017 |
Grote A, Lustigman S, Ghedin E. Lessons from the genomes and transcriptomes of filarial nematodes. Molecular and Biochemical Parasitology. PMID 28126543 DOI: 10.1016/J.Molbiopara.2017.01.004 |
0.362 |
|
| 2016 |
Bennuru S, Cotton JA, Ribeiro JM, Grote A, Harsha B, Holroyd N, Mhashilkar A, Molina DM, Randall AZ, Shandling AD, Unnasch TR, Ghedin E, Berriman M, Lustigman S, Nutman TB. Stage-Specific Transcriptome and Proteome Analyses of the Filarial Parasite Onchocerca volvulus and Its Wolbachia Endosymbiont. Mbio. 7. PMID 27881553 DOI: 10.1128/Mbio.02028-16 |
0.334 |
|
| 2016 |
Cotton JA, Bennuru S, Grote A, Harsha B, Tracey A, Beech R, Doyle SR, Dunn M, Hotopp JC, Holroyd N, Kikuchi T, Lambert O, Mhashilkar A, Mutowo P, Nursimulu N, ... ... Lustigman S, et al. The genome of Onchocerca volvulus, agent of river blindness. Nature Microbiology. 2: 16216. PMID 27869790 DOI: 10.1038/Nmicrobiol.2016.216 |
0.359 |
|
| 2016 |
Hess JA, Zhan B, Torigian AR, Patton JB, Petrovsky N, Zhan T, Bottazzi ME, Hotez PJ, Klei TR, Lustigman S, Abraham D. The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice. Plos Neglected Tropical Diseases. 10: e0004797. PMID 27387453 DOI: 10.1371/Journal.Pntd.0004797 |
0.427 |
|
| 2016 |
Hotez PJ, Strych U, Lustigman S, Bottazzi ME. Human anthelminthic vaccines: Rationale and challenges. Vaccine. PMID 27171753 DOI: 10.1016/J.Vaccine.2016.03.112 |
0.41 |
|
| 2016 |
Arumugam S, Wei J, Liu Z, Abraham D, Bell A, Bottazzi ME, Hotez PJ, Zhan B, Lustigman S, Klei TR. Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection. Plos Neglected Tropical Diseases. 10: e0004586. PMID 27045170 DOI: 10.1371/Journal.Pntd.0004586 |
0.403 |
|
| 2016 |
Jiang J, Fisher EM, Concannon M, Lustigman S, Shen H, Murasko DM. Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1. Vaccine. PMID 26795365 DOI: 10.1016/J.Vaccine.2016.01.003 |
0.387 |
|
| 2015 |
Turner HC, Walker M, Lustigman S, Taylor DW, Basáñez MG. Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme. Plos Neglected Tropical Diseases. 9: e0003938. PMID 26186715 DOI: 10.1371/Journal.Pntd.0003938 |
0.392 |
|
| 2015 |
Makepeace BL, Babayan SA, Lustigman S, Taylor DW. The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa. Expert Review of Vaccines. 14: 1163-5. PMID 26091691 DOI: 10.1586/14760584.2015.1059281 |
0.384 |
|
| 2015 |
Gooyit M, Tricoche N, Javor S, Lustigman S, Janda KD. Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting. Acs Medicinal Chemistry Letters. 6: 339-43. PMID 25815157 DOI: 10.1021/Ml500516R |
0.358 |
|
| 2015 |
Guo J, Yang Y, Xiao W, Sun W, Yu H, Du L, Lustigman S, Jiang S, Kou Z, Zhou Y. A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein. Vaccine. 33: 1974-80. PMID 25736195 DOI: 10.1016/J.Vaccine.2015.02.053 |
0.381 |
|
| 2015 |
Bulman CA, Bidlow CM, Lustigman S, Cho-Ngwa F, Williams D, Rascón AA, Tricoche N, Samje M, Bell A, Suzuki B, Lim KC, Supakorndej N, Supakorndej P, Wolfe AR, Knudsen GM, et al. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. Plos Neglected Tropical Diseases. 9: e0003534. PMID 25700363 DOI: 10.1371/Journal.Pntd.0003534 |
0.355 |
|
| 2015 |
Hotez PJ, Bottazzi ME, Zhan B, Makepeace BL, Klei TR, Abraham D, Taylor DW, Lustigman S. The Onchocerciasis Vaccine for Africa--TOVA--Initiative. Plos Neglected Tropical Diseases. 9: e0003422. PMID 25634641 DOI: 10.1371/Journal.Pntd.0003422 |
0.428 |
|
| 2014 |
Lustigman S, Melnikow E, Anand SB, Contreras A, Nandi V, Liu J, Bell A, Unnasch TR, Rogers MB, Ghedin E. Potential involvement of Brugia malayi cysteine proteases in the maintenance of the endosymbiotic relationship with Wolbachia. International Journal For Parasitology. Drugs and Drug Resistance. 4: 267-77. PMID 25516837 DOI: 10.1016/J.Ijpddr.2014.08.001 |
0.378 |
|
| 2014 |
Hotez PJ, Bottazzi ME, Tseng CT, Zhan B, Lustigman S, Du L, Jiang S. Calling for rapid development of a safe and effective MERS vaccine. Microbes and Infection / Institut Pasteur. 16: 529-31. PMID 24931059 DOI: 10.1016/J.Micinf.2014.05.002 |
0.352 |
|
| 2014 |
Arumugam S, Wei J, Ward D, Abraham D, Lustigman S, Zhan B, Klei TR. Vaccination with a genetically modified Brugia malayi cysteine protease inhibitor-2 reduces adult parasite numbers and affects the fertility of female worms following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae. International Journal For Parasitology. 44: 675-9. PMID 24929131 DOI: 10.1016/J.Ijpara.2014.05.003 |
0.408 |
|
| 2014 |
Gooyit M, Tricoche N, Lustigman S, Janda KD. Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting. Journal of Medicinal Chemistry. 57: 5792-9. PMID 24918716 DOI: 10.1021/Jm5006435 |
0.322 |
|
| 2014 |
Hess JA, Zhan B, Bonne-Année S, Deckman JM, Bottazzi ME, Hotez PJ, Klei TR, Lustigman S, Abraham D. Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. International Journal For Parasitology. 44: 637-46. PMID 24907553 DOI: 10.1016/J.Ijpara.2014.04.006 |
0.408 |
|
| 2014 |
Jiang J, Fisher EM, Hensley SE, Lustigman S, Murasko DM, Shen H. Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines. Vaccine. 32: 2696-702. PMID 24681229 DOI: 10.1016/J.Vaccine.2014.03.046 |
0.39 |
|
| 2014 |
Arumugam S, Zhan B, Abraham D, Ward D, Lustigman S, Klei TR. Vaccination with recombinant Brugia malayi cystatin proteins alters worm migration, homing and final niche selection following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae. Parasites & Vectors. 7: 43. PMID 24450869 DOI: 10.1186/1756-3305-7-43 |
0.442 |
|
| 2014 |
Chen WH, Du L, Chag SM, Ma C, Tricoche N, Tao X, Seid CA, Hudspeth EM, Lustigman S, Tseng CT, Bottazzi ME, Hotez PJ, Zhan B, Jiang S. Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Human Vaccines & Immunotherapeutics. 10: 648-58. PMID 24355931 DOI: 10.4161/Hv.27464 |
0.383 |
|
| 2013 |
Melnikow E, Xu S, Liu J, Bell AJ, Ghedin E, Unnasch TR, Lustigman S. A potential role for the interaction of Wolbachia surface proteins with the Brugia malayi glycolytic enzymes and cytoskeleton in maintenance of endosymbiosis. Plos Neglected Tropical Diseases. 7: e2151. PMID 23593519 DOI: 10.1371/Journal.Pntd.0002151 |
0.325 |
|
| 2012 |
Jiang S, Bottazzi ME, Du L, Lustigman S, Tseng CT, Curti E, Jones K, Zhan B, Hotez PJ. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome. Expert Review of Vaccines. 11: 1405-13. PMID 23252385 DOI: 10.1586/Erv.12.126 |
0.376 |
|
| 2012 |
Lopez-Perez M, Villasis E, Machado RL, Póvoa MM, Vinetz JM, Blair S, Gamboa D, Lustigman S. Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms. Plos One. 7: e47913. PMID 23118907 DOI: 10.1371/Journal.Pone.0047913 |
0.308 |
|
| 2012 |
Villasis E, Lopez-Perez M, Torres K, Gamboa D, Neyra V, Bendezu J, Tricoche N, Lobo C, Vinetz JM, Lustigman S. Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malaria Journal. 11: 361. PMID 23110555 DOI: 10.1186/1475-2875-11-361 |
0.401 |
|
| 2012 |
Wang J, Tricoche N, Du L, Hunter M, Zhan B, Goud G, Didier ES, Liu J, Lu L, Marx PA, Jiang S, Lustigman S. The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates. Plos One. 7: e37019. PMID 22615877 DOI: 10.1371/Journal.Pone.0037019 |
0.426 |
|
| 2012 |
McCarthy JS, Lustigman S, Yang GJ, Barakat RM, GarcÃa HH, Sripa B, Willingham AL, Prichard RK, Basáñez MG. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. Plos Neglected Tropical Diseases. 6: e1601. PMID 22545166 DOI: 10.1371/Journal.Pntd.0001601 |
0.323 |
|
| 2012 |
Lustigman S, Prichard RK, Gazzinelli A, Grant WN, Boatin BA, McCarthy JS, Basáñez MG. A research agenda for helminth diseases of humans: the problem of helminthiases. Plos Neglected Tropical Diseases. 6: e1582. PMID 22545164 DOI: 10.1371/Journal.Pntd.0001582 |
0.37 |
|
| 2012 |
Prichard RK, Basáñez MG, Boatin BA, McCarthy JS, GarcÃa HH, Yang GJ, Sripa B, Lustigman S. A research agenda for helminth diseases of humans: intervention for control and elimination. Plos Neglected Tropical Diseases. 6: e1549. PMID 22545163 DOI: 10.1371/Journal.Pntd.0001549 |
0.363 |
|
| 2012 |
Boatin BA, Basáñez MG, Prichard RK, Awadzi K, Barakat RM, GarcÃa HH, Gazzinelli A, Grant WN, McCarthy JS, N'Goran EK, Osei-Atweneboana MY, Sripa B, Yang GJ, Lustigman S. A research agenda for helminth diseases of humans: towards control and elimination. Plos Neglected Tropical Diseases. 6: e1547. PMID 22545161 DOI: 10.1371/Journal.Pntd.0001547 |
0.325 |
|
| 2012 |
Lustigman S, Geldhof P, Grant WN, Osei-Atweneboana MY, Sripa B, Basáñez MG. A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases. Plos Neglected Tropical Diseases. 6: e1445. PMID 22545160 DOI: 10.1371/Journal.Pntd.0001445 |
0.331 |
|
| 2012 |
Lustigman S, Abraham D, Klei TR. Antifilarial Vaccine Development: Present and Future Approaches Parasitic Helminths: Targets, Screens, Drugs and Vaccines. 377-398. DOI: 10.1002/9783527652969.ch23 |
0.34 |
|
| 2012 |
Lustigman S, Mckerrow JH, Bottazzi ME. Vaccines Linked to Chemotherapy: A New Approach to Control Helminth Infections Parasitic Helminths: Targets, Screens, Drugs and Vaccines. 357-375. DOI: 10.1002/9783527652969.ch22 |
0.313 |
|
| 2011 |
Abraham D, Hess JA, Mejia R, Nolan TJ, Lok JB, Lustigman S, Nutman TB. Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. Vaccine. 29: 8134-40. PMID 21856350 DOI: 10.1016/J.Vaccine.2011.08.030 |
0.429 |
|
| 2011 |
Melnikow E, Xu S, Liu J, Li L, Oksov Y, Ghedin E, Unnasch TR, Lustigman S. Interaction of a Wolbachia WSP-like protein with a nuclear-encoded protein of Brugia malayi. International Journal For Parasitology. 41: 1053-61. PMID 21782817 DOI: 10.1016/J.Ijpara.2011.05.008 |
0.328 |
|
| 2011 |
Garner AL, Gloeckner C, Tricoche N, Zakhari JS, Samje M, Cho-Ngwa F, Lustigman S, Janda KD. Design, synthesis, and biological activities of closantel analogues: structural promiscuity and its impact on Onchocerca volvulus. Journal of Medicinal Chemistry. 54: 3963-72. PMID 21534605 DOI: 10.1021/Jm200364N |
0.323 |
|
| 2010 |
Cho-Ngwa F, Liu J, Lustigman S. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age. Plos Neglected Tropical Diseases. 4: e800. PMID 20808763 DOI: 10.1371/journal.pntd.0000800 |
0.332 |
|
| 2010 |
Zhao G, Du L, Xiao W, Sun S, Lin Y, Chen M, Kou Z, He Y, Lustigman S, Jiang S, Zheng BJ, Zhou Y. Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant. Vaccine. 28: 7233-40. PMID 20732469 DOI: 10.1016/J.Vaccine.2010.08.049 |
0.377 |
|
| 2010 |
Bergquist R, Lustigman S. Control of important helminthic infections vaccine development as part of the solution. Advances in Parasitology. 73: 297-326. PMID 20627146 DOI: 10.1016/S0065-308X(10)73010-4 |
0.437 |
|
| 2010 |
Zhan B, Perally S, Brophy PM, Xue J, Goud G, Liu S, Deumic V, de Oliveira LM, Bethony J, Bottazzi ME, Jiang D, Gillespie P, Xiao SH, Gupta R, Loukas A, ... ... Lustigman S, et al. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infection and Immunity. 78: 1552-63. PMID 20145100 DOI: 10.1128/Iai.00848-09 |
0.383 |
|
| 2010 |
Gloeckner C, Garner AL, Mersha F, Oksov Y, Tricoche N, Eubanks LM, Lustigman S, Kaufmann GF, Janda KD. Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proceedings of the National Academy of Sciences of the United States of America. 107: 3424-9. PMID 20142509 DOI: 10.1073/Pnas.0915125107 |
0.341 |
|
| 2009 |
Brindley PJ, Mitreva M, Ghedin E, Lustigman S. Helminth genomics: The implications for human health. Plos Neglected Tropical Diseases. 3: e538. PMID 19855829 DOI: 10.1371/Journal.Pntd.0000538 |
0.37 |
|
| 2009 |
He Y, Barker SJ, MacDonald AJ, Yu Y, Cao L, Li J, Parhar R, Heck S, Hartmann S, Golenbock DT, Jiang S, Libri NA, Semper AE, Rosenberg WM, Lustigman S. Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 4005-16. PMID 19299698 DOI: 10.4049/Jimmunol.0800531 |
0.348 |
|
| 2008 |
Xiao W, Du L, Liang C, Guan J, Jiang S, Lustigman S, He Y, Zhou Y. Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines. Vaccine. 26: 5022-9. PMID 18675867 DOI: 10.1016/J.Vaccine.2008.07.028 |
0.376 |
|
| 2008 |
Jones MK, Lustigman S, Loukas A. Tracking the odysseys of juvenile schistosomes to understand host interactions. Plos Neglected Tropical Diseases. 2: e257. PMID 18628997 DOI: 10.1371/Journal.Pntd.0000257 |
0.322 |
|
| 2008 |
MacDonald AJ, Libri NA, Lustigman S, Barker SJ, Whelan MA, Semper AE, Rosenberg WM. A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its action. Clinical and Experimental Immunology. 152: 265-73. PMID 18341617 DOI: 10.1111/J.1365-2249.2008.03623.X |
0.31 |
|
| 2008 |
Al-Riyami L, Egan CA, Bradley JE, Lustigman S, Harnett W. Failure of ES-62 to inhibit T-helper type 1 responses to other filarial nematode antigens Parasite Immunology. 30: 304-308. PMID 18312502 DOI: 10.1111/J.1365-3024.2008.01024.X |
0.37 |
|
| 2007 |
Lustigman S, McCarter JP. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis. Plos Neglected Tropical Diseases. 1: e76. PMID 17989789 DOI: 10.1371/Journal.Pntd.0000076 |
0.344 |
|
| 2007 |
Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, Crabtree J, Allen JE, Delcher AL, Guiliano DB, Miranda-Saavedra D, Angiuoli SV, Creasy T, Amedeo P, Haas B, El-Sayed NM, ... ... Lustigman S, et al. Draft genome of the filarial nematode parasite Brugia malayi. Science (New York, N.Y.). 317: 1756-60. PMID 17885136 DOI: 10.1126/Science.1145406 |
0.341 |
|
| 2007 |
Fujiwara RT, Zhan B, Mendez S, Loukas A, Bueno LL, Wang Y, Plieskatt J, Oksov Y, Lustigman S, Bottazzi ME, Hotez P, Bethony JM. Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clinical and Vaccine Immunology : Cvi. 14: 281-7. PMID 17267592 DOI: 10.1128/Cvi.00404-06 |
0.456 |
|
| 2007 |
Don TA, Oksov Y, Lustigman S, Loukas A. Saposin-like proteins from the intestine of the blood-feeding hookworm, Ancylostoma caninum Parasitology. 134: 427-436. PMID 17109779 DOI: 10.1017/S003118200600148X |
0.353 |
|
| 2006 |
He Y, Li J, Heck S, Lustigman S, Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design. Journal of Virology. 80: 5757-67. PMID 16731915 DOI: 10.1128/Jvi.00083-06 |
0.39 |
|
| 2006 |
He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. Journal of Immunology (Baltimore, Md. : 1950). 176: 6085-92. PMID 16670317 DOI: 10.4049/Jimmunol.176.10.6085 |
0.364 |
|
| 2006 |
Tchakouté VL, Graham SP, Jensen SA, Makepeace BL, Nfon CK, Njongmeta LM, Lustigman S, Enyong PA, Tanya VN, Bianco AE, Trees AJ. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. Proceedings of the National Academy of Sciences of the United States of America. 103: 5971-6. PMID 16585501 DOI: 10.1073/Pnas.0601385103 |
0.432 |
|
| 2006 |
Williamson AL, Lustigman S, Oksov Y, Deumic V, Plieskatt J, Mendez S, Zhan B, Bottazzi ME, Hotez PJ, Loukas A. Ancylostoma caninum MTP-1, an astacin-like metalloprotease secreted by infective hookworm larvae, is involved in tissue migration. Infection and Immunity. 74: 961-7. PMID 16428741 DOI: 10.1128/Iai.74.2.961-967.2006 |
0.382 |
|
| 2005 |
Bethony J, Loukas A, Smout M, Brooker S, Mendez S, Plieskatt J, Goud G, Bottazzi ME, Zhan B, Wang Y, Williamson A, Lustigman S, Correa-Oliveira R, Xiao S, Hotez PJ. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1743-5. PMID 16037096 DOI: 10.1096/Fj.05-3936Fje |
0.474 |
|
| 2005 |
MacDonald AJ, Cao L, He Y, Zhao Q, Jiang S, Lustigman S. rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens. Vaccine. 23: 3446-52. PMID 15837368 DOI: 10.1016/J.Vaccine.2005.01.098 |
0.351 |
|
| 2005 |
Castilho L, Lustigman S, Reid M, Cavasini CE, Rossit A, Couto A, Costa FF, Machado RD. Ss Polymorphisms Carried on GPB in Brazilian Malaria Infected and Non-Infected Individuals. Blood. 106: 1342-1342. DOI: 10.1182/Blood.V106.11.1342.1342 |
0.32 |
|
| 2004 |
Lustigman S, Zhang J, Liu J, Oksov Y, Hashmi S. RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting. Molecular and Biochemical Parasitology. 138: 165-70. PMID 15555728 DOI: 10.1016/J.Molbiopara.2004.08.003 |
0.354 |
|
| 2004 |
Macdonald AJ, Tawe W, Leon O, Cao L, Liu J, Oksov Y, Abraham D, Lustigman S. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity Parasite Immunology. 26: 53-62. PMID 15198646 DOI: 10.1111/J.0141-9838.2004.00685.X |
0.428 |
|
| 2004 |
Kerepesi LA, Nolan TJ, Schad GA, Lustigman S, Herbert DR, Keiser PB, Nutman TB, Krolewiecki AJ, Abraham D. Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice. The Journal of Infectious Diseases. 189: 1282-90. PMID 15031798 DOI: 10.1086/382484 |
0.376 |
|
| 2004 |
Abraham D, Leon O, Schnyder-Candrian S, Wang CC, Galioto AM, Kerepesi LA, Lee JJ, Lustigman S. Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae. Infection and Immunity. 72: 810-7. PMID 14742524 DOI: 10.1128/Iai.72.2.810-817.2004 |
0.336 |
|
| 2004 |
Hashmi S, Zhang J, Oksov Y, Lustigman S. The Caenorhabditis elegans cathepsin Z-like cysteine protease, Ce-CPZ-1, has a multifunctional role during the worms' development. The Journal of Biological Chemistry. 279: 6035-45. PMID 14630920 DOI: 10.1074/Jbc.M312346200 |
0.323 |
|
| 2003 |
Ligas JA, Kerepesi LA, Galioto AM, Lustigman S, Nolan TJ, Schad GA, Abraham D. Specificity and mechanism of immunoglobulin M (IgM)- and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice. Infection and Immunity. 71: 6835-43. PMID 14638770 DOI: 10.1128/Iai.71.12.6835-6843.2003 |
0.371 |
|
| 2003 |
Lustigman S, MacDonald AJ, Abraham D. CD4+-dependent immunity to Onchocerca volvulus third-stage larvae in humans and the mouse vaccination model: common ground and distinctions. International Journal For Parasitology. 33: 1161-71. PMID 13678632 DOI: 10.1016/S0020-7519(03)00170-X |
0.482 |
|
| 2003 |
Lobo CA, Rodriguez M, Hou G, Perkins M, Oskov Y, Lustigman S. Characterization of PfRhop148, a novel rhoptry protein of Plasmodium falciparum. Molecular and Biochemical Parasitology. 128: 59-65. PMID 12706797 DOI: 10.1016/S0166-6851(03)00050-1 |
0.309 |
|
| 2002 |
Herbert DR, Nolan TJ, Schad GA, Lustigman S, Abraham D. Immunoaffinity-isolated antigens induce protective immunity against larval Strongyloides stercoralis in mice. Experimental Parasitology. 100: 112-20. PMID 12054701 DOI: 10.1016/S0014-4894(02)00008-5 |
0.426 |
|
| 2002 |
MacDonald AJ, Turaga PS, Harmon-Brown C, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S. Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. Infection and Immunity. 70: 2796-804. PMID 12010965 DOI: 10.1128/Iai.70.6.2796-2804.2002 |
0.348 |
|
| 2002 |
Lustigman S, James ER, Tawe W, Abraham D. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends in Parasitology. 18: 135-41. PMID 11854092 DOI: 10.1016/S1471-4922(01)02211-5 |
0.39 |
|
| 2002 |
McCarthy JS, Wieseman M, Tropea J, Kaslow D, Abraham D, Lustigman S, Tuan R, Guderian RH, Nutman TB. Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infection and Immunity. 70: 851-8. PMID 11796620 DOI: 10.1128/Iai.70.2.851-858.2002 |
0.454 |
|
| 2002 |
Hashmi S, Britton C, Liu J, Guiliano DB, Oksov Y, Lustigman S. Cathepsin L is essential for embryogenesis and development of Caenorhabditis elegans. The Journal of Biological Chemistry. 277: 3477-86. PMID 11707440 DOI: 10.1074/Jbc.M106117200 |
0.348 |
|
| 2001 |
Hashmi S, Tawe W, Lustigman S. Caenorhabditis elegans and the study of gene function in parasites Trends in Parasitology. 17: 387-393. PMID 11685900 DOI: 10.1016/S1471-4922(01)01986-9 |
0.33 |
|
| 2001 |
Abraham D, Leon O, Leon S, Lustigman S. Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus Infection and Immunity. 69: 262-270. PMID 11119514 DOI: 10.1128/Iai.69.1.262-270.2001 |
0.44 |
|
| 2000 |
Tawe W, Pearlman E, Unnasch TR, Lustigman S. Angiogenic activity of Onchocerca volvulus recombinant proteins similar to vespid venom antigen 5 Molecular and Biochemical Parasitology. 109: 91-99. PMID 10960168 DOI: 10.1016/S0166-6851(00)00231-0 |
0.326 |
|
| 2000 |
Vincent JA, Lustigman S, Zhang S, Weil GJ. A comparison of newer tests for the diagnosis of onchocerciasis. Annals of Tropical Medicine and Parasitology. 94: 253-8. PMID 10884870 DOI: 10.1080/00034980050006438 |
0.324 |
|
| 2000 |
Graham SP, Lustigman S, Trees AJ, Bianco AE. Onchocerca volvulus: Comparative analysis of antibody responses to recombinant antigens in two animal models of onchocerciasis Experimental Parasitology. 94: 158-162. PMID 10831380 DOI: 10.1006/Expr.2000.4487 |
0.388 |
|
| 2000 |
Lizotte-Waniewski M, Tawe W, Guiliano DB, Lu W, Liu J, Williams SA, Lustigman S. Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries Infection and Immunity. 68: 3491-3501. PMID 10816503 DOI: 10.1128/Iai.68.6.3491-3501.2000 |
0.437 |
|
| 2000 |
Turaga PS, Tierney TJ, Bennett KE, McCarthy MC, Simonek SC, Enyong PA, Moukatte DW, Lustigman S. Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens. Infection and Immunity. 68: 1905-11. PMID 10722581 DOI: 10.1128/Iai.68.4.1905-1911.2000 |
0.359 |
|
| 1998 |
Joseph GT, Huima T, Lustigman S. Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1. Molecular and Biochemical Parasitology. 96: 177-83. PMID 9851616 DOI: 10.1016/S0166-6851(98)00094-2 |
0.325 |
|
| 1998 |
Johnson EH, Schynder-Candrian S, Rajan TV, Nelson FK, Lustigman S, Abraham D. Immune responses to third stage larvae of Onchocerca volvulus in interferon-gamma and interleukin-4 knockout mice Parasite Immunology. 20: 319-324. PMID 9717193 DOI: 10.1046/J.1365-3024.1998.00148.X |
0.334 |
|
| 1998 |
Lustigman S, Joseph G, Huima T, Abraham D. Induction of protective immunity against Onchocerca volvulus larvae by immunization with recombinant proteins Parasitology International. 47: 268. DOI: 10.1016/S1383-5769(98)80750-2 |
0.35 |
|
| 1997 |
Joseph GT, McCarthy JS, Huima T, Mair KF, Kass PH, Boussinesq M, Goodrick L, Bradley JE, Lustigman S. Onchocera volvulus: characterization of a highly immunogenic Gln-rich protein. Molecular and Biochemical Parasitology. 90: 55-68. PMID 9497032 DOI: 10.1016/S0166-6851(97)00132-1 |
0.392 |
|
| 1997 |
Irvine M, Johnson EH, Lustigman S. Identification of larval-stage-specific antigens of Onchocerca volvulus uniquely recognized by putative immune sera from humans and vaccination sera from animal models Annals of Tropical Medicine and Parasitology. 91: 67-77. PMID 9093431 DOI: 10.1080/00034983.1997.11813113 |
0.421 |
|
| 1996 |
Lustigman S, McKerrow JH, Shah K, Lui J, Huima T, Hough M, Brotman B. Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae Journal of Biological Chemistry. 271: 30181-30189. PMID 8939969 DOI: 10.1074/Jbc.271.47.30181 |
0.302 |
|
| 1995 |
Tume C, Sun E, Titanji V, Bathurst I, Barr P, Hough M, Weiss N, Chakravarti B, Wahi M, Lackey A, Staunton C, Lustigman S, Mckerrow JH. Onchocerca volvulus: Identification and Characterization of an Immunogenic Eggshell Protein (Oveg 1) Experimental Parasitology. 81: 445-452. PMID 8542985 DOI: 10.1006/Expr.1995.1137 |
0.417 |
|
| 1994 |
Irvine M, Huima T, Prince AM, Lustigman S. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a highly immunogenic calponin-like protein Molecular and Biochemical Parasitology. 65: 135-146. PMID 7935620 DOI: 10.1016/0166-6851(94)90122-8 |
0.398 |
|
| 1993 |
Chandrashekar R, Ogunrinade AF, Henry RW, Lustigman S, Weil GJ. Onchocerca volvulus: monoclonal antibodies to immune complex-associated parasite antigens. Experimental Parasitology. 77: 224-34. PMID 7690712 DOI: 10.1006/Expr.1993.1079 |
0.367 |
|
| 1993 |
Lustigman S. Molting, enzymes and new targets for chemotherapy of onchocerca volvulus Parasitology Today. 9: 294-297. DOI: 10.1016/0169-4758(93)90128-3 |
0.331 |
|
| 1992 |
Prince AM, Brotman B, Johnson EH, Smith A, Pascual D, Lustigman S. Onchocerca volvulus: Immunization of chimpanzees with X-irradiated third-stage (L3) larvae Experimental Parasitology. 74: 239-250. PMID 1582477 DOI: 10.1016/0014-4894(92)90147-3 |
0.437 |
|
| 1992 |
Lustigman S, Brotman B, Johnson EH, Smith AB, Huima T, Prince AM. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a microfilarial surface-associated antigen Molecular and Biochemical Parasitology. 50: 79-93. PMID 1542318 DOI: 10.1016/0166-6851(92)90246-G |
0.402 |
|
| 1991 |
Lustigman S, Brotman B, Huima T, Prince AM. Characterization of an Onchocerca volvulus cDNA clone encoding a genus specific antigen present in infective larvae and adult worms Molecular and Biochemical Parasitology. 45: 65-75. PMID 2052041 DOI: 10.1016/0166-6851(91)90028-5 |
0.402 |
|
| 1990 |
Lustigman S, Anders RF, Brown GV, Coppel RL. The mature-parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum associates with the erythrocyte membrane skeletal protein, band 4.1 Molecular and Biochemical Parasitology. 38: 261-270. PMID 2183050 DOI: 10.1016/0166-6851(90)90029-L |
0.326 |
|
| Show low-probability matches. |